Quarterly Holdings Report
for
Fidelity® Series Growth Company Fund
February 28, 2023
XS7-NPRT1-0423
1.968012.109
Common Stocks - 97.7% | |||
Shares | Value ($) | ||
COMMUNICATION SERVICES - 7.1% | |||
Entertainment - 0.9% | |||
Electronic Arts, Inc. | 5,354 | 593,973 | |
Netflix, Inc. (a) | 291,529 | 93,910,237 | |
Roblox Corp. (a) | 4,500 | 164,880 | |
Roku, Inc. Class A (a) | 151,376 | 9,792,513 | |
The Walt Disney Co. (a) | 71,776 | 7,149,607 | |
111,611,210 | |||
Interactive Media & Services - 5.6% | |||
Alphabet, Inc.: | |||
Class A (a) | 4,812,580 | 433,420,955 | |
Class C (a) | 2,562,460 | 231,390,138 | |
Epic Games, Inc. (a)(b)(c) | 11,800 | 8,802,446 | |
IAC, Inc. (a) | 13,500 | 701,190 | |
Meta Platforms, Inc. Class A (a) | 182,130 | 31,861,822 | |
Snap, Inc. Class A (a) | 692,881 | 7,032,742 | |
713,209,293 | |||
Media - 0.0% | |||
The Trade Desk, Inc. (a) | 12,000 | 671,520 | |
Wireless Telecommunication Services - 0.6% | |||
T-Mobile U.S., Inc. (a) | 528,353 | 75,121,230 | |
TOTAL COMMUNICATION SERVICES | 900,613,253 | ||
CONSUMER DISCRETIONARY - 19.5% | |||
Auto Components - 0.0% | |||
Mobileye Global, Inc. (d) | 104,300 | 4,120,893 | |
Automobiles - 2.2% | |||
Neutron Holdings, Inc. (a)(b)(c) | 438,358 | 11,397 | |
Rad Power Bikes, Inc. (a)(b)(c) | 249,183 | 954,371 | |
Rivian Automotive, Inc. (a)(d) | 2,173,019 | 41,939,267 | |
Tesla, Inc. (a) | 1,126,955 | 231,825,913 | |
274,730,948 | |||
Hotels, Restaurants & Leisure - 1.7% | |||
Airbnb, Inc. Class A (a) | 95,100 | 11,723,928 | |
Booking Holdings, Inc. (a) | 31,872 | 80,444,928 | |
Chipotle Mexican Grill, Inc. (a) | 13,370 | 19,935,740 | |
Dutch Bros, Inc. (a)(d) | 42,500 | 1,417,375 | |
Expedia, Inc. (a) | 83,900 | 9,142,583 | |
Hyatt Hotels Corp. Class A (a) | 8,383 | 974,440 | |
Marriott International, Inc. Class A | 119,050 | 20,148,022 | |
McDonald's Corp. | 5,825 | 1,537,276 | |
Penn Entertainment, Inc. (a) | 760,000 | 23,202,800 | |
Shake Shack, Inc. Class A (a)(d) | 35,636 | 1,988,132 | |
Sonder Holdings, Inc. (a)(d) | 1,217,572 | 1,254,099 | |
Sonder Holdings, Inc.: | |||
rights (a)(c) | 14,240 | 4,414 | |
rights (a)(c) | 14,240 | 3,702 | |
rights (a)(c) | 14,239 | 2,990 | |
rights (a)(c) | 14,239 | 2,563 | |
rights (a)(c) | 14,238 | 2,136 | |
rights (a)(c) | 14,238 | 1,851 | |
Starbucks Corp. | 172,553 | 17,615,936 | |
Sweetgreen, Inc. Class A (a) | 470,251 | 4,100,589 | |
Trip.com Group Ltd. ADR (a) | 235,800 | 8,382,690 | |
Yum China Holdings, Inc. | 210,812 | 12,380,989 | |
214,267,183 | |||
Household Durables - 0.5% | |||
Lennar Corp. Class A | 507,869 | 49,131,247 | |
Purple Innovation, Inc. (a)(d) | 1,569,187 | 6,778,888 | |
Toll Brothers, Inc. | 19,200 | 1,150,848 | |
57,060,983 | |||
Internet & Direct Marketing Retail - 6.1% | |||
Alibaba Group Holding Ltd. sponsored ADR (a) | 111,100 | 9,753,469 | |
Amazon.com, Inc. (a) | 6,602,260 | 622,130,960 | |
Etsy, Inc. (a) | 32,081 | 3,894,954 | |
JD.com, Inc. sponsored ADR | 59,429 | 2,641,025 | |
Lyft, Inc. (a) | 711,078 | 7,110,780 | |
Pdd Holdings, Inc. ADR (a) | 70,300 | 6,167,419 | |
Revolve Group, Inc. (a) | 465,800 | 12,613,864 | |
RumbleON, Inc. Class B (a)(d) | 257,700 | 2,342,493 | |
Uber Technologies, Inc. (a) | 1,879,404 | 62,508,977 | |
Vipshop Holdings Ltd. ADR (a) | 327,500 | 4,876,475 | |
Wayfair LLC Class A (a) | 882,397 | 35,728,255 | |
Zomato Ltd. (a) | 5,119,000 | 3,313,770 | |
773,082,441 | |||
Leisure Products - 0.0% | |||
Peloton Interactive, Inc. Class A (a) | 43,642 | 563,855 | |
Multiline Retail - 0.7% | |||
Dollar General Corp. | 119,140 | 25,769,982 | |
Dollar Tree, Inc. (a) | 108,394 | 15,747,480 | |
Ollie's Bargain Outlet Holdings, Inc. (a) | 560,682 | 32,261,642 | |
Target Corp. | 77,113 | 12,993,541 | |
86,772,645 | |||
Specialty Retail - 2.8% | |||
Fanatics, Inc. Class A (a)(b)(c) | 180,405 | 14,257,407 | |
Five Below, Inc. (a) | 66,600 | 13,606,380 | |
Floor & Decor Holdings, Inc. Class A (a)(d) | 97,400 | 8,942,294 | |
Lowe's Companies, Inc. | 424,223 | 87,283,882 | |
RH (a) | 36,529 | 10,923,267 | |
Ross Stores, Inc. | 134,300 | 14,845,522 | |
The Home Depot, Inc. | 337,677 | 100,134,738 | |
TJX Companies, Inc. | 1,353,472 | 103,675,955 | |
353,669,445 | |||
Textiles, Apparel & Luxury Goods - 5.5% | |||
Canada Goose Holdings, Inc. (a) | 339,671 | 6,385,168 | |
Crocs, Inc. (a) | 238,900 | 29,076,519 | |
Deckers Outdoor Corp. (a) | 154,170 | 64,188,680 | |
Li Ning Co. Ltd. | 543,000 | 4,617,582 | |
lululemon athletica, Inc. (a) | 1,370,358 | 423,714,694 | |
NIKE, Inc. Class B | 401,854 | 47,736,237 | |
On Holding AG (a)(d) | 1,414,964 | 30,945,263 | |
Skechers U.S.A., Inc. Class A (sub. vtg.) (a) | 1,617,079 | 71,976,186 | |
Tory Burch LLC (a)(b)(c)(e) | 248,840 | 7,738,924 | |
686,379,253 | |||
TOTAL CONSUMER DISCRETIONARY | 2,450,647,646 | ||
CONSUMER STAPLES - 3.7% | |||
Beverages - 1.6% | |||
Celsius Holdings, Inc. (a) | 114,300 | 10,378,440 | |
Constellation Brands, Inc. Class A (sub. vtg.) | 16,300 | 3,646,310 | |
Keurig Dr. Pepper, Inc. | 671,671 | 23,206,233 | |
Monster Beverage Corp. (a) | 414,035 | 42,132,202 | |
PepsiCo, Inc. | 236,464 | 41,033,598 | |
The Coca-Cola Co. | 1,426,107 | 84,867,628 | |
205,264,411 | |||
Food & Staples Retailing - 0.8% | |||
Costco Wholesale Corp. | 121,044 | 58,607,084 | |
Kroger Co. | 236,840 | 10,217,278 | |
Ocado Group PLC (a) | 34,320 | 226,555 | |
Performance Food Group Co. (a) | 84,168 | 4,763,067 | |
Sysco Corp. | 171,000 | 12,751,470 | |
Walmart, Inc. | 75,200 | 10,688,176 | |
97,253,630 | |||
Food Products - 0.4% | |||
Archer Daniels Midland Co. | 27,300 | 2,173,080 | |
Bunge Ltd. | 197,154 | 18,828,207 | |
Kellogg Co. | 119,500 | 7,879,830 | |
Mondelez International, Inc. | 87,017 | 5,671,768 | |
The Hershey Co. | 77,000 | 18,350,640 | |
The Real Good Food Co. LLC: | |||
Class B (c) | 131,479 | 1 | |
Class B unit (f) | 131,479 | 507,509 | |
The Real Good Food Co., Inc. (a) | 11,600 | 44,776 | |
53,455,811 | |||
Household Products - 0.4% | |||
Church & Dwight Co., Inc. | 53,621 | 4,492,367 | |
Colgate-Palmolive Co. | 119,491 | 8,758,690 | |
Procter & Gamble Co. | 235,678 | 32,419,866 | |
45,670,923 | |||
Personal Products - 0.1% | |||
Olaplex Holdings, Inc. (a)(d) | 1,738,700 | 8,554,404 | |
The Beauty Health Co. (a) | 149,898 | 1,890,214 | |
The Beauty Health Co. (a)(b) | 553,828 | 6,983,771 | |
17,428,389 | |||
Tobacco - 0.4% | |||
JUUL Labs, Inc. Class A (a)(b)(c) | 13,297 | 161,027 | |
Philip Morris International, Inc. | 556,000 | 54,098,800 | |
54,259,827 | |||
TOTAL CONSUMER STAPLES | 473,332,991 | ||
ENERGY - 3.1% | |||
Energy Equipment & Services - 0.6% | |||
Baker Hughes Co. Class A | 453,700 | 13,883,220 | |
Halliburton Co. | 895,800 | 32,454,834 | |
Schlumberger Ltd. | 586,400 | 31,202,344 | |
77,540,398 | |||
Oil, Gas & Consumable Fuels - 2.5% | |||
Cameco Corp. (d) | 681,000 | 18,618,540 | |
Devon Energy Corp. | 229,900 | 12,396,208 | |
EOG Resources, Inc. | 333,400 | 37,680,868 | |
EQT Corp. | 127,500 | 4,230,450 | |
Exxon Mobil Corp. | 9,500 | 1,044,145 | |
Hess Corp. | 1,078,406 | 145,261,288 | |
Pioneer Natural Resources Co. | 125,800 | 25,211,578 | |
Range Resources Corp. | 1,129,300 | 30,423,342 | |
Reliance Industries Ltd. | 851,959 | 23,942,373 | |
Valero Energy Corp. | 69,400 | 9,142,062 | |
307,950,854 | |||
TOTAL ENERGY | 385,491,252 | ||
FINANCIALS - 1.3% | |||
Banks - 0.6% | |||
Bank of America Corp. | 857,617 | 29,416,263 | |
HDFC Bank Ltd. sponsored ADR | 409,122 | 27,673,012 | |
JPMorgan Chase & Co. | 110,023 | 15,771,797 | |
Wells Fargo & Co. | 56,800 | 2,656,536 | |
75,517,608 | |||
Capital Markets - 0.7% | |||
BlackRock, Inc. Class A | 41,997 | 28,953,992 | |
Charles Schwab Corp. | 771,351 | 60,103,670 | |
89,057,662 | |||
Consumer Finance - 0.0% | |||
Discover Financial Services | 21,882 | 2,450,784 | |
Diversified Financial Services - 0.0% | |||
Ant International Co. Ltd. Class C (a)(b)(c) | 617,086 | 931,800 | |
TOTAL FINANCIALS | 167,957,854 | ||
HEALTH CARE - 15.6% | |||
Biotechnology - 8.1% | |||
4D Pharma PLC (a)(c)(d) | 596,200 | 119,475 | |
AbbVie, Inc. | 125,149 | 19,260,431 | |
Absci Corp. (a) | 954,083 | 2,022,656 | |
ACADIA Pharmaceuticals, Inc. (a) | 917,071 | 18,974,199 | |
Akouos, Inc. (CVR) (c) | 200,563 | 158,445 | |
Alector, Inc. (a) | 442,760 | 3,781,170 | |
Allovir, Inc. (a)(d) | 461,910 | 3,117,893 | |
Alnylam Pharmaceuticals, Inc. (a) | 650,931 | 124,620,740 | |
Amgen, Inc. | 120,104 | 27,823,293 | |
Apellis Pharmaceuticals, Inc. (a) | 39,800 | 2,606,104 | |
Arcutis Biotherapeutics, Inc. (a) | 148,400 | 2,401,112 | |
Argenx SE ADR (a) | 225,926 | 82,693,435 | |
Arrowhead Pharmaceuticals, Inc. (a) | 39,659 | 1,280,986 | |
Ars Pharmaceuticals, Inc. (a) | 234,484 | 2,091,597 | |
Ascendis Pharma A/S sponsored ADR (a) | 9,489 | 1,054,133 | |
aTyr Pharma, Inc. (a) | 470,831 | 993,453 | |
Avidity Biosciences, Inc. (a) | 409,500 | 9,705,150 | |
Axcella Health, Inc. (a) | 949,347 | 550,811 | |
Beam Therapeutics, Inc. (a)(d) | 200,500 | 8,068,120 | |
BeiGene Ltd. ADR (a)(d) | 179,039 | 40,217,531 | |
Biogen, Inc. (a) | 1,842 | 497,082 | |
BioNTech SE ADR | 14,902 | 1,938,005 | |
BioXcel Therapeutics, Inc. (a)(d) | 314,798 | 10,048,352 | |
Caris Life Sciences, Inc. (b)(c) | 396,011 | 2,217,662 | |
Century Therapeutics, Inc. (a) | 330,300 | 1,489,653 | |
Cerevel Therapeutics Holdings (a) | 1,653,216 | 44,124,335 | |
Codiak Biosciences, Inc. (a) | 432,962 | 207,822 | |
Codiak Biosciences, Inc. warrants 9/15/27 (a) | 104,600 | 5,938 | |
CRISPR Therapeutics AG (a)(d) | 221,500 | 10,924,380 | |
Cyclerion Therapeutics, Inc. (a) | 165,167 | 107,524 | |
Cyclerion Therapeutics, Inc. (a)(b) | 150,550 | 98,008 | |
Day One Biopharmaceuticals, Inc. (a) | 291,700 | 5,373,114 | |
Denali Therapeutics, Inc. (a) | 45,274 | 1,229,189 | |
Deverra Therapeutics, Inc. (a)(c) | 20,487 | 35,238 | |
Disc Medicine, Inc. (a) | 2,360 | 59,000 | |
Disc Medicine, Inc. rights (a)(c) | 16,600 | 0 | |
EQRx, Inc. (a)(d) | 2,642,149 | 5,971,257 | |
EQRx, Inc.: | |||
rights (a)(c) | 90,566 | 58,868 | |
rights (a)(c) | 38,814 | 17,466 | |
Evelo Biosciences, Inc. (a)(d) | 1,519,461 | 941,914 | |
Foghorn Therapeutics, Inc. (a) | 304,983 | 1,747,553 | |
G1 Therapeutics, Inc. (a) | 86,200 | 312,044 | |
Generation Bio Co. (a) | 647,360 | 2,563,546 | |
Geron Corp. (a) | 797,600 | 2,217,328 | |
Idorsia Ltd. (a)(d) | 145,670 | 1,927,110 | |
Immunocore Holdings PLC ADR (a) | 95,270 | 5,225,560 | |
Immunovant, Inc. (a) | 450,900 | 7,877,223 | |
Inhibrx, Inc. (a)(d) | 70,100 | 1,686,606 | |
Intarcia Therapeutics, Inc. warrants 12/6/24 (a)(c) | 7,022 | 0 | |
Invivyd, Inc. (a)(d) | 1,644,752 | 2,861,868 | |
Ionis Pharmaceuticals, Inc. (a) | 2,190,369 | 78,634,247 | |
Janux Therapeutics, Inc. (a) | 99,800 | 1,659,674 | |
Karuna Therapeutics, Inc. (a) | 390,799 | 77,933,137 | |
Kineta, Inc. | 10,998 | 72,807 | |
Kinnate Biopharma, Inc. (a) | 33,700 | 177,936 | |
Legend Biotech Corp. ADR (a) | 584,400 | 26,987,592 | |
Lexicon Pharmaceuticals, Inc. (a) | 144,122 | 324,275 | |
Lyell Immunopharma, Inc. (a)(d) | 435,600 | 936,540 | |
Moderna, Inc. (a) | 264,241 | 36,679,293 | |
Monte Rosa Therapeutics, Inc. (a) | 388,205 | 2,360,286 | |
Morphic Holding, Inc. (a) | 333,314 | 14,172,511 | |
Nuvalent, Inc. Class A (a) | 346,676 | 10,500,816 | |
Omega Therapeutics, Inc. (a) | 433,125 | 2,797,988 | |
ORIC Pharmaceuticals, Inc. (a) | 131,108 | 580,808 | |
Poseida Therapeutics, Inc. (a) | 785,859 | 4,471,538 | |
Prometheus Biosciences, Inc. (a) | 80,600 | 9,864,634 | |
Prothena Corp. PLC (a) | 429,305 | 23,938,047 | |
PTC Therapeutics, Inc. (a) | 289,530 | 12,643,775 | |
RAPT Therapeutics, Inc. (a) | 197,600 | 5,819,320 | |
Recursion Pharmaceuticals, Inc. (a)(d) | 648,900 | 5,288,535 | |
Regeneron Pharmaceuticals, Inc. (a) | 87,121 | 66,248,551 | |
Relay Therapeutics, Inc. (a)(d) | 367,400 | 5,933,510 | |
Roivant Sciences Ltd. (a) | 2,925,400 | 23,666,486 | |
Rubius Therapeutics, Inc. (a) | 1,163,117 | 169,699 | |
Sage Therapeutics, Inc. (a) | 703,313 | 29,285,953 | |
Saluda Medical Pty Ltd. warrants (a)(b)(c) | 16,498 | 41,080 | |
Sana Biotechnology, Inc. (a)(d) | 168,300 | 617,661 | |
Scholar Rock Holding Corp. (a) | 507,934 | 4,358,074 | |
Scholar Rock Holding Corp. warrants 12/31/25 (a)(b) | 44,550 | 162,014 | |
Seagen, Inc. (a) | 5,700 | 1,024,233 | |
Seres Therapeutics, Inc. (a) | 1,449,248 | 7,318,702 | |
Shattuck Labs, Inc. (a) | 323,200 | 1,525,504 | |
Sigilon Therapeutics, Inc. (a) | 57,000 | 62,130 | |
SpringWorks Therapeutics, Inc. (b) | 125,200 | 3,594,492 | |
SpringWorks Therapeutics, Inc. (a)(d) | 777,871 | 24,814,085 | |
Synlogic, Inc. (a) | 620,300 | 434,210 | |
Tango Therapeutics, Inc. (a) | 364,056 | 1,904,013 | |
Taysha Gene Therapies, Inc. (a) | 143,308 | 144,741 | |
TG Therapeutics, Inc. (a) | 475,500 | 7,617,510 | |
Twist Bioscience Corp. (a) | 294,600 | 5,732,916 | |
Tyra Biosciences, Inc. (a) | 27,400 | 361,954 | |
uniQure B.V. (a) | 50,549 | 1,059,507 | |
UNITY Biotechnology, Inc. (a)(d) | 109,800 | 494,100 | |
UNITY Biotechnology, Inc. warrants 8/22/27 (a) | 700,000 | 85,916 | |
Vaxcyte, Inc. (a) | 322,580 | 13,216,103 | |
Vera Therapeutics, Inc. (a) | 206,282 | 1,532,675 | |
Vertex Pharmaceuticals, Inc. (a) | 66,493 | 19,302,253 | |
Verve Therapeutics, Inc. (a) | 113,500 | 2,156,500 | |
Vor Biopharma, Inc. (a) | 480,932 | 2,683,601 | |
Zai Lab Ltd. ADR (a) | 162,386 | 6,032,640 | |
Zentalis Pharmaceuticals, Inc. (a) | 188,444 | 3,567,245 | |
1,014,296,196 | |||
Health Care Equipment & Supplies - 3.1% | |||
Abbott Laboratories | 9,901 | 1,007,130 | |
Blink Health LLC Series A1 (a)(b)(c) | 8,589 | 371,045 | |
DexCom, Inc. (a) | 351,784 | 39,051,542 | |
Figs, Inc. Class A (a)(d) | 122,500 | 1,128,225 | |
Insulet Corp. (a) | 524,365 | 144,913,511 | |
Intuitive Surgical, Inc. (a) | 194,823 | 44,690,448 | |
Novocure Ltd. (a) | 1,410,474 | 108,564,184 | |
Oddity Tech Ltd. (a)(b)(c) | 2,226 | 968,666 | |
Outset Medical, Inc. (a) | 418,254 | 9,540,374 | |
Presbia PLC (a)(c) | 454,926 | 6,824 | |
PROCEPT BioRobotics Corp. (a) | 378,762 | 14,184,637 | |
Shockwave Medical, Inc. (a) | 165,967 | 31,573,562 | |
396,000,148 | |||
Health Care Providers & Services - 1.4% | |||
Alignment Healthcare, Inc. (a) | 461,922 | 4,591,505 | |
AmerisourceBergen Corp. | 41,700 | 6,486,852 | |
Centene Corp. (a) | 18,690 | 1,278,396 | |
Guardant Health, Inc. (a) | 131,800 | 4,071,302 | |
Humana, Inc. | 79,243 | 39,226,870 | |
McKesson Corp. | 32,800 | 11,473,768 | |
The Oncology Institute, Inc. (a)(b) | 377,375 | 532,099 | |
UnitedHealth Group, Inc. | 221,454 | 105,398,817 | |
173,059,609 | |||
Health Care Technology - 0.0% | |||
DNA Script (a)(b)(c) | 85 | 58,907 | |
DNA Script (a)(b)(c) | 324 | 224,540 | |
283,447 | |||
Life Sciences Tools & Services - 0.7% | |||
10X Genomics, Inc. (a) | 38,800 | 1,843,776 | |
10X Genomics, Inc. Class B (a)(f) | 640,857 | 30,453,525 | |
Akoya Biosciences, Inc. (a) | 1,000 | 11,530 | |
Danaher Corp. | 38,233 | 9,463,814 | |
Olink Holding AB ADR (a) | 348,535 | 8,169,660 | |
Seer, Inc. (a) | 340,017 | 1,390,670 | |
Thermo Fisher Scientific, Inc. | 41,474 | 22,468,954 | |
WuXi AppTec Co. Ltd. (H Shares) (f) | 282,540 | 3,007,391 | |
Wuxi Biologics (Cayman), Inc. (a)(f) | 1,835,310 | 12,847,454 | |
89,656,774 | |||
Pharmaceuticals - 2.3% | |||
Adimab LLC (a)(b)(c)(e) | 762,787 | 31,205,616 | |
Arvinas Holding Co. LLC (a) | 52,200 | 1,599,930 | |
Atea Pharmaceuticals, Inc. (a) | 1,679,012 | 5,943,702 | |
Bristol-Myers Squibb Co. | 131,165 | 9,045,138 | |
DICE Therapeutics, Inc. (a) | 90,500 | 2,700,520 | |
Dragonfly Therapeutics, Inc. (a)(b)(c) | 126,113 | 1,823,594 | |
Eli Lilly & Co. | 311,000 | 96,789,420 | |
Fulcrum Therapeutics, Inc. (a) | 312,101 | 1,885,090 | |
GH Research PLC (a) | 295,400 | 2,829,932 | |
Hansoh Pharmaceutical Group Co. Ltd. (f) | 314,400 | 564,762 | |
Harmony Biosciences Holdings, Inc. (a) | 599,223 | 26,383,789 | |
Intra-Cellular Therapies, Inc. (a) | 974,409 | 47,775,273 | |
Merck & Co., Inc. | 40,500 | 4,302,720 | |
Novo Nordisk A/S Series B sponsored ADR | 201,100 | 28,353,089 | |
Nuvation Bio, Inc. (a) | 1,373,519 | 2,664,627 | |
OptiNose, Inc. (a) | 1,580,525 | 2,844,945 | |
OptiNose, Inc. warrants (a) | 206,400 | 135,749 | |
Pfizer, Inc. | 24,600 | 998,022 | |
Pharvaris BV (a) | 43,300 | 359,823 | |
Pliant Therapeutics, Inc. (a) | 500,700 | 15,952,302 | |
Sienna Biopharmaceuticals, Inc. (a) | 589,618 | 1 | |
Skyhawk Therapeutics, Inc. (a)(b)(c) | 126,063 | 1,448,464 | |
Theravance Biopharma, Inc. (a)(d) | 240,045 | 2,592,486 | |
UCB SA | 26,600 | 2,289,612 | |
Ventyx Biosciences, Inc. (a) | 76,700 | 3,317,275 | |
293,805,881 | |||
TOTAL HEALTH CARE | 1,967,102,055 | ||
INDUSTRIALS - 5.6% | |||
Aerospace & Defense - 1.5% | |||
AeroVironment, Inc. (a) | 35,700 | 3,060,918 | |
Lockheed Martin Corp. | 67,000 | 31,775,420 | |
Raytheon Technologies Corp. | 174,400 | 17,106,896 | |
Space Exploration Technologies Corp. Class A (a)(b)(c) | 1,375,690 | 105,928,130 | |
The Boeing Co. (a) | 127,536 | 25,704,881 | |
183,576,245 | |||
Air Freight & Logistics - 0.1% | |||
Delhivery Private Ltd. | 646,600 | 2,703,914 | |
United Parcel Service, Inc. Class B | 88,384 | 16,129,196 | |
18,833,110 | |||
Airlines - 0.9% | |||
Delta Air Lines, Inc. (a) | 673,790 | 25,833,109 | |
JetBlue Airways Corp. (a) | 96,614 | 801,896 | |
Ryanair Holdings PLC sponsored ADR (a) | 8,478 | 786,504 | |
Southwest Airlines Co. | 829,137 | 27,842,420 | |
Spirit Airlines, Inc. | 642,933 | 11,778,533 | |
United Airlines Holdings, Inc. (a) | 458,025 | 23,798,979 | |
Wheels Up Experience, Inc.: | |||
rights (a)(c) | 23,018 | 5,064 | |
rights (a)(c) | 23,018 | 4,143 | |
rights (a)(c) | 23,018 | 3,453 | |
Wizz Air Holdings PLC (a)(f) | 736,883 | 22,868,081 | |
113,722,182 | |||
Construction & Engineering - 0.2% | |||
Fluor Corp. (a) | 433,800 | 15,907,446 | |
MasTec, Inc. (a)(d) | 47,500 | 4,641,700 | |
Quanta Services, Inc. | 50,600 | 8,166,840 | |
28,715,986 | |||
Electrical Equipment - 0.4% | |||
Eaton Corp. PLC | 85,724 | 14,995,699 | |
Emerson Electric Co. | 204,049 | 16,876,893 | |
Generac Holdings, Inc. (a) | 114,600 | 13,753,146 | |
Nextracker, Inc. Class A | 51,600 | 1,570,704 | |
NuScale Power Corp. (a)(d) | 274,000 | 2,835,900 | |
50,032,342 | |||
Industrial Conglomerates - 0.1% | |||
3M Co. | 22,180 | 2,389,673 | |
Honeywell International, Inc. | 41,183 | 7,885,721 | |
10,275,394 | |||
Machinery - 0.9% | |||
Caterpillar, Inc. | 112,660 | 26,987,703 | |
Deere & Co. | 98,052 | 41,107,320 | |
Fortive Corp. | 33,900 | 2,259,774 | |
Illinois Tool Works, Inc. | 63,653 | 14,841,333 | |
Ingersoll Rand, Inc. | 82,944 | 4,816,558 | |
Xylem, Inc. (d) | 204,117 | 20,952,610 | |
110,965,298 | |||
Professional Services - 0.0% | |||
LegalZoom.com, Inc. (a) | 226,400 | 1,849,688 | |
Road & Rail - 1.5% | |||
Avis Budget Group, Inc. (a) | 483,697 | 106,248,883 | |
Bird Global, Inc. (a)(b) | 228,339 | 46,170 | |
Bird Global, Inc.: | |||
Stage 1 rights (a)(c) | 28,568 | 0 | |
Stage 2 rights (a)(c) | 28,568 | 0 | |
Stage 3 rights (a)(c) | 28,567 | 0 | |
CSX Corp. | 73,900 | 2,253,211 | |
Hertz Global Holdings, Inc. (a)(d) | 816,200 | 15,107,862 | |
Union Pacific Corp. | 296,661 | 61,491,892 | |
185,148,018 | |||
TOTAL INDUSTRIALS | 703,118,263 | ||
INFORMATION TECHNOLOGY - 39.6% | |||
Communications Equipment - 0.7% | |||
Arista Networks, Inc. (a) | 130,432 | 18,090,918 | |
Ciena Corp. (a) | 950,397 | 45,828,143 | |
Infinera Corp. (a)(d) | 3,301,675 | 23,342,842 | |
87,261,903 | |||
Electronic Equipment & Components - 0.0% | |||
Coherent Corp. (a)(d) | 167,990 | 7,245,409 | |
TE Connectivity Ltd. | 2,041 | 259,860 | |
7,505,269 | |||
IT Services - 4.2% | |||
Accenture PLC Class A | 129,700 | 34,441,835 | |
Block, Inc. Class A (a) | 52,785 | 4,050,193 | |
Cloudflare, Inc. (a)(d) | 1,266,681 | 76,013,527 | |
IBM Corp. | 134,195 | 17,351,414 | |
MasterCard, Inc. Class A | 386,149 | 137,194,878 | |
MongoDB, Inc. Class A (a) | 8,941 | 1,873,318 | |
Okta, Inc. (a) | 112,881 | 8,047,286 | |
PayPal Holdings, Inc. (a) | 163,827 | 12,057,667 | |
Shopify, Inc. Class A (a) | 502,990 | 20,709,401 | |
Snowflake, Inc. (a) | 72,025 | 11,119,220 | |
Toast, Inc. (a)(d) | 1,809,000 | 34,226,280 | |
Twilio, Inc. Class A (a) | 2,000 | 134,420 | |
Visa, Inc. Class A | 765,712 | 168,410,697 | |
X Holdings I, Inc. (b)(c) | 2,263 | 826,900 | |
526,457,036 | |||
Semiconductors & Semiconductor Equipment - 13.3% | |||
Advanced Micro Devices, Inc. (a) | 819,136 | 64,367,707 | |
Allegro MicroSystems LLC (a) | 4,600 | 200,928 | |
Applied Materials, Inc. | 446,685 | 51,882,463 | |
ASML Holding NV | 21,685 | 13,395,475 | |
Broadcom, Inc. | 42,125 | 25,034,466 | |
Cirrus Logic, Inc. (a) | 355,566 | 36,534,407 | |
Enphase Energy, Inc. (a) | 83,400 | 17,558,202 | |
First Solar, Inc. (a) | 238,600 | 40,356,804 | |
GlobalFoundries, Inc. (a) | 91,800 | 5,998,212 | |
KLA Corp. | 57,086 | 21,657,287 | |
Lam Research Corp. | 18,100 | 8,796,781 | |
Lattice Semiconductor Corp. (a) | 39,800 | 3,381,408 | |
Marvell Technology, Inc. | 881,241 | 39,788,031 | |
Micron Technology, Inc. | 174,031 | 10,062,472 | |
Monolithic Power Systems, Inc. | 37,200 | 18,015,588 | |
NVIDIA Corp. | 4,864,340 | 1,129,305,174 | |
onsemi (a) | 190,300 | 14,731,123 | |
Qualcomm, Inc. | 156,709 | 19,358,263 | |
Silicon Laboratories, Inc. (a) | 390,739 | 69,758,634 | |
SiTime Corp. (a) | 171,885 | 21,339,523 | |
SolarEdge Technologies, Inc. (a) | 9,100 | 2,893,072 | |
Taiwan Semiconductor Manufacturing Co. Ltd. sponsored ADR | 131,168 | 11,420,798 | |
Teradyne, Inc. | 80,350 | 8,126,599 | |
Texas Instruments, Inc. | 153,194 | 26,265,111 | |
Wolfspeed, Inc. (a)(d) | 141,329 | 10,455,519 | |
1,670,684,047 | |||
Software - 10.6% | |||
Adobe, Inc. (a) | 187,012 | 60,582,537 | |
Atlassian Corp. PLC (a) | 9,626 | 1,581,841 | |
Autodesk, Inc. (a) | 126,942 | 25,222,106 | |
Bill Holdings, Inc. (a) | 17,600 | 1,489,488 | |
Clear Secure, Inc. | 1,500 | 46,110 | |
Crowdstrike Holdings, Inc. (a) | 93,833 | 11,324,705 | |
Datadog, Inc. Class A (a) | 64,330 | 4,922,532 | |
Elastic NV (a) | 48,394 | 2,856,214 | |
HubSpot, Inc. (a) | 54,617 | 21,129,133 | |
Intuit, Inc. | 79,294 | 32,286,931 | |
Microsoft Corp. | 2,644,536 | 659,600,169 | |
Nutanix, Inc. Class A (a) | 3,495,910 | 98,759,458 | |
Oracle Corp. | 1,559,604 | 136,309,390 | |
Paycom Software, Inc. (a) | 14,000 | 4,046,840 | |
Paylocity Holding Corp. (a) | 26,497 | 5,103,587 | |
RingCentral, Inc. (a) | 48,742 | 1,610,436 | |
Riskified Ltd. (a) | 187,874 | 1,033,307 | |
Salesforce.com, Inc. (a) | 1,151,349 | 188,372,210 | |
Samsara, Inc. (a)(d) | 52,000 | 866,320 | |
SentinelOne, Inc. (a) | 48,100 | 769,119 | |
ServiceNow, Inc. (a) | 55,900 | 24,158,303 | |
Stripe, Inc. Class B (a)(b)(c) | 43,500 | 942,645 | |
UiPath, Inc. Class A (a) | 1,473,448 | 21,865,968 | |
Workday, Inc. Class A (a) | 32,732 | 6,070,804 | |
Zoom Video Communications, Inc. Class A (a) | 184,453 | 13,758,349 | |
Zscaler, Inc. (a) | 91,065 | 11,943,175 | |
1,336,651,677 | |||
Technology Hardware, Storage & Peripherals - 10.8% | |||
Apple, Inc. | 8,379,128 | 1,235,167,252 | |
Pure Storage, Inc. Class A (a)(d) | 4,038,661 | 115,263,385 | |
Samsung Electronics Co. Ltd. | 132,303 | 6,068,440 | |
1,356,499,077 | |||
TOTAL INFORMATION TECHNOLOGY | 4,985,059,009 | ||
MATERIALS - 1.8% | |||
Chemicals - 1.0% | |||
Albemarle Corp. | 49,100 | 12,486,621 | |
CF Industries Holdings, Inc. | 351,400 | 30,181,746 | |
Cibus Corp. Series C (a)(b)(c)(e) | 2,311,010 | 4,622,020 | |
Corteva, Inc. | 581,300 | 36,209,177 | |
DuPont de Nemours, Inc. | 231,946 | 16,939,016 | |
The Mosaic Co. | 324,300 | 17,249,517 | |
117,688,097 | |||
Containers & Packaging - 0.0% | |||
Sealed Air Corp. | 73,200 | 3,558,984 | |
Metals & Mining - 0.8% | |||
Barrick Gold Corp. (Canada) (d) | 385,700 | 6,232,822 | |
Freeport-McMoRan, Inc. | 1,945,700 | 79,715,329 | |
Rio Tinto PLC sponsored ADR (d) | 247,000 | 17,223,310 | |
103,171,461 | |||
TOTAL MATERIALS | 224,418,542 | ||
REAL ESTATE - 0.3% | |||
Equity Real Estate Investment Trusts (REITs) - 0.2% | |||
American Tower Corp. | 81,498 | 16,137,419 | |
Equinix, Inc. | 6,800 | 4,680,236 | |
20,817,655 | |||
Real Estate Management & Development - 0.1% | |||
CBRE Group, Inc. (a) | 138,000 | 11,749,320 | |
WeWork, Inc. (a) | 512,038 | 593,964 | |
12,343,284 | |||
TOTAL REAL ESTATE | 33,160,939 | ||
UTILITIES - 0.1% | |||
Electric Utilities - 0.1% | |||
ORSTED A/S (f) | 100,100 | 8,713,010 | |
TOTAL COMMON STOCKS (Cost $6,820,955,643) | 12,299,614,814 | ||
Preferred Stocks - 1.9% | |||
Shares | Value ($) | ||
Convertible Preferred Stocks - 1.8% | |||
COMMUNICATION SERVICES - 0.2% | |||
Interactive Media & Services - 0.2% | |||
ByteDance Ltd. Series E1 (a)(b)(c) | 84,766 | 16,849,785 | |
Reddit, Inc.: | |||
Series B(a)(b)(c) | 37,935 | 1,445,324 | |
Series E(a)(b)(c) | 5,127 | 195,339 | |
Series F(a)(b)(c) | 40,428 | 1,540,307 | |
20,030,755 | |||
CONSUMER DISCRETIONARY - 0.1% | |||
Automobiles - 0.0% | |||
Rad Power Bikes, Inc.: | |||
Series A(a)(b)(c) | 32,487 | 124,425 | |
Series C(a)(b)(c) | 127,831 | 489,593 | |
Series D(a)(b)(c) | 215,900 | 826,897 | |
1,440,915 | |||
Hotels, Restaurants & Leisure - 0.1% | |||
Discord, Inc. Series I (a)(b)(c) | 1,400 | 472,290 | |
MOD Super Fast Pizza Holdings LLC Series 3 (a)(b)(c)(e) | 23,686 | 6,401,378 | |
6,873,668 | |||
Internet & Direct Marketing Retail - 0.0% | |||
Instacart, Inc.: | |||
Series H(a)(b)(c) | 13,904 | 549,903 | |
Series I(a)(b)(c) | 6,341 | 250,787 | |
Meesho Series F (a)(b)(c) | 62,461 | 4,871,958 | |
5,672,648 | |||
Textiles, Apparel & Luxury Goods - 0.0% | |||
Freenome, Inc.: | |||
Series C(a)(b)(c) | 190,858 | 1,486,784 | |
Series D(a)(b)(c) | 91,538 | 747,865 | |
Laronde, Inc. Series B (a)(b)(c) | 66,432 | 1,247,593 | |
3,482,242 | |||
TOTAL CONSUMER DISCRETIONARY | 17,469,473 | ||
CONSUMER STAPLES - 0.1% | |||
Food & Staples Retailing - 0.1% | |||
GoBrands, Inc.: | |||
Series G(a)(b)(c) | 26,833 | 3,594,280 | |
Series H(a)(b)(c) | 21,372 | 2,862,779 | |
6,457,059 | |||
Food Products - 0.0% | |||
AgBiome LLC: | |||
Series C(a)(b)(c) | 338,565 | 2,265,000 | |
Series D(a)(b)(c) | 126,371 | 835,312 | |
Bowery Farming, Inc. Series C1 (a)(b)(c) | 27,136 | 551,132 | |
3,651,444 | |||
Tobacco - 0.0% | |||
JUUL Labs, Inc. Series E (a)(b)(c) | 6,648 | 80,507 | |
TOTAL CONSUMER STAPLES | 10,189,010 | ||
FINANCIALS - 0.0% | |||
Diversified Financial Services - 0.0% | |||
Paragon Biosciences Emalex Capital, Inc.: | |||
Series B(a)(b)(c) | 198,234 | 2,146,874 | |
Series C(a)(b)(c) | 115,792 | 1,254,027 | |
Series D1(b)(c) | 214,900 | 2,327,367 | |
Series D2(b)(c) | 44,427 | 481,144 | |
6,209,412 | |||
HEALTH CARE - 0.7% | |||
Biotechnology - 0.5% | |||
Altos Labs, Inc. Series B (b)(c) | 122,084 | 2,337,713 | |
Ankyra Therapeutics Series B (a)(b)(c) | 257,347 | 1,016,521 | |
Apogee Therapeutics Series B (b)(c) | 565,933 | 1,870,160 | |
Asimov, Inc. Series B (a)(b)(c) | 15,783 | 803,828 | |
Bright Peak Therapeutics AG Series B (a)(b)(c) | 239,403 | 699,057 | |
Caris Life Sciences, Inc. Series D (a)(b)(c) | 255,590 | 1,431,304 | |
Castle Creek Biosciences, Inc.: | |||
Series D1(b)(c) | 4,460 | 908,680 | |
Series D2(b)(c) | 1,412 | 287,681 | |
Cleerly, Inc. Series C (b)(c) | 272,438 | 3,165,730 | |
Deep Genomics, Inc. Series C (a)(b)(c) | 129,534 | 1,299,226 | |
Dianthus Therapeutics, Inc. Series A (b)(c) | 287,993 | 1,223,970 | |
Element Biosciences, Inc.: | |||
Series B(a)(b)(c) | 250,956 | 4,128,226 | |
Series C(a)(b)(c) | 101,911 | 1,676,436 | |
ElevateBio LLC Series C (a)(b)(c) | 332,500 | 1,057,350 | |
Fog Pharmaceuticals, Inc. Series D (b)(c) | 247,595 | 2,664,890 | |
Generate Biomedicines Series B (a)(b)(c) | 157,390 | 1,306,337 | |
Inscripta, Inc.: | |||
Series D(a)(b)(c) | 308,833 | 1,306,364 | |
Series E(a)(b)(c) | 222,357 | 940,570 | |
Intarcia Therapeutics, Inc. Series EE (a)(b)(c) | 116,544 | 1 | |
Korro Bio, Inc.: | |||
Series B1(a)(b)(c) | 241,420 | 519,053 | |
Series B2(a)(b)(c) | 226,657 | 498,645 | |
LifeMine Therapeutics, Inc. Series C (b)(c) | 1,780,790 | 3,116,383 | |
National Resilience, Inc.: | |||
Series B(a)(b)(c) | 251,448 | 15,270,437 | |
Series C(a)(b)(c) | 44,850 | 2,723,741 | |
Odyssey Therapeutics, Inc. Series B (b)(c) | 468,023 | 3,201,277 | |
Quell Therapeutics Ltd. Series B (a)(b)(c) | 760,965 | 1,034,912 | |
SalioGen Therapeutics, Inc. Series B (a)(b)(c) | 8,766 | 654,031 | |
Saluda Medical Pty Ltd. Series D (a)(b)(c) | 109,988 | 1,272,561 | |
Sonoma Biotherapeutics, Inc.: | |||
Series B(a)(b)(c) | 481,325 | 755,680 | |
Series B1(a)(b)(c) | 256,702 | 492,868 | |
T-Knife Therapeutics, Inc. Series B (a)(b)(c) | 199,356 | 783,469 | |
Treeline Biosciences: | |||
Series A(a)(b)(c) | 289,700 | 2,372,643 | |
Series A1(b)(c) | 143,637 | 1,205,114 | |
62,024,858 | |||
Health Care Equipment & Supplies - 0.1% | |||
Blink Health LLC Series C (a)(b)(c) | 197,068 | 8,513,338 | |
Kardium, Inc. Series D6 (a)(b)(c) | 1,136,853 | 1,125,484 | |
9,638,822 | |||
Health Care Providers & Services - 0.0% | |||
Boundless Bio, Inc. Series B (a)(b)(c) | 616,102 | 560,653 | |
Conformal Medical, Inc. Series C (a)(b)(c) | 240,750 | 857,070 | |
Scorpion Therapeutics, Inc. Series B (a)(b)(c) | 242,077 | 375,219 | |
1,792,942 | |||
Health Care Technology - 0.1% | |||
Aledade, Inc.: | |||
Series B1(a)(b)(c) | 22,992 | 1,226,393 | |
Series E1(b)(c) | 17,916 | 955,639 | |
DNA Script: | |||
Series B(a)(b)(c) | 4 | 2,772 | |
Series C(a)(b)(c) | 2,060 | 1,427,634 | |
Omada Health, Inc. Series E (a)(b)(c) | 435,062 | 1,557,522 | |
PrognomIQ, Inc.: | |||
Series A5(a)(b)(c) | 83,544 | 137,012 | |
Series B(a)(b)(c) | 198,721 | 463,020 | |
Series C(b)(c) | 66,506 | 176,906 | |
Wugen, Inc. Series B (a)(b)(c) | 96,718 | 515,507 | |
6,462,405 | |||
Pharmaceuticals - 0.0% | |||
Castle Creek Pharmaceutical Holdings, Inc.: | |||
Series B(a)(b)(c) | 4,910 | 1,087,663 | |
Series C(a)(b)(c) | 2,570 | 569,306 | |
Galvanize Therapeutics Series B (b)(c) | 1,018,908 | 1,721,955 | |
Nohla Therapeutics, Inc. Series B (a)(b)(c) | 3,126,919 | 31 | |
3,378,955 | |||
TOTAL HEALTH CARE | 83,297,982 | ||
INDUSTRIALS - 0.3% | |||
Aerospace & Defense - 0.3% | |||
Space Exploration Technologies Corp. Series G (a)(b)(c) | 53,937 | 41,531,490 | |
Construction & Engineering - 0.0% | |||
Beta Technologies, Inc.: | |||
Series A(a)(b)(c) | 10,986 | 836,254 | |
Series B, 6.00%(b)(c) | 17,147 | 1,345,011 | |
2,181,265 | |||
TOTAL INDUSTRIALS | 43,712,755 | ||
INFORMATION TECHNOLOGY - 0.3% | |||
Electronic Equipment & Components - 0.0% | |||
Enevate Corp. Series E (a)(b)(c) | 814,561 | 480,591 | |
Menlo Micro, Inc. Series C (b)(c) | 959,784 | 892,599 | |
1,373,190 | |||
IT Services - 0.0% | |||
AppNexus, Inc. Series E (Escrow) (a)(b)(c) | 209,665 | 6,567 | |
Semiconductors & Semiconductor Equipment - 0.1% | |||
Alif Semiconductor Series C (b)(c) | 43,548 | 777,332 | |
Astera Labs, Inc.: | |||
Series A(b)(c) | 85,993 | 764,478 | |
Series B(b)(c) | 14,642 | 130,167 | |
Series C(a)(b)(c) | 371,500 | 3,302,635 | |
Series D(b)(c) | 291,891 | 2,594,911 | |
GaN Systems, Inc.: | |||
Series F1(a)(b)(c) | 50,937 | 572,532 | |
Series F2(a)(b)(c) | 26,897 | 302,322 | |
SiMa.ai: | |||
Series B(a)(b)(c) | 338,113 | 2,180,829 | |
Series B1(b)(c) | 22,648 | 169,181 | |
Xsight Labs Ltd. Series D (a)(b)(c) | 167,386 | 1,216,896 | |
12,011,283 | |||
Software - 0.2% | |||
Bolt Technology OU Series E (a)(b)(c) | 13,569 | 1,697,546 | |
Databricks, Inc.: | |||
Series G(a)(b)(c) | 53,226 | 2,828,962 | |
Series H(a)(b)(c) | 56,454 | 3,000,530 | |
Dataminr, Inc. Series D (a)(b)(c) | 442,241 | 7,133,347 | |
Evozyne LLC Series A (a)(b)(c) | 101,400 | 1,580,826 | |
Skyryse, Inc. Series B (a)(b)(c) | 117,170 | 2,355,117 | |
Stripe, Inc. Series H (a)(b)(c) | 19,200 | 416,064 | |
Tenstorrent, Inc. Series C1 (a)(b)(c) | 21,000 | 1,181,040 | |
20,193,432 | |||
TOTAL INFORMATION TECHNOLOGY | 33,584,472 | ||
MATERIALS - 0.1% | |||
Chemicals - 0.0% | |||
Farmers Business Network, Inc. Series G (a)(b)(c) | 36,990 | 1,709,678 | |
Metals & Mining - 0.1% | |||
Diamond Foundry, Inc. Series C (a)(b)(c) | 355,446 | 12,607,670 | |
TOTAL MATERIALS | 14,317,348 | ||
UTILITIES - 0.0% | |||
Independent Power and Renewable Electricity Producers - 0.0% | |||
Redwood Materials Series C (a)(b)(c) | 16,253 | 479,464 | |
TOTAL CONVERTIBLE PREFERRED STOCKS | 229,290,671 | ||
Nonconvertible Preferred Stocks - 0.1% | |||
CONSUMER DISCRETIONARY - 0.1% | |||
Automobiles - 0.0% | |||
Neutron Holdings, Inc. Series 1D (a)(b)(c) | 5,678,726 | 147,647 | |
Waymo LLC Series A2 (a)(b)(c) | 10,731 | 551,037 | |
698,684 | |||
Internet & Direct Marketing Retail - 0.1% | |||
Circle Internet Financial Ltd. Series E (b)(c) | 137,221 | 4,594,159 | |
TOTAL CONSUMER DISCRETIONARY | 5,292,843 | ||
HEALTH CARE - 0.0% | |||
Pharmaceuticals - 0.0% | |||
Castle Creek Pharmaceutical Holdings, Inc. Series A4 (a)(b)(c) | 13,511 | 2,923,916 | |
Faraday Pharmaceuticals, Inc. Series B (a)(b)(c) | 219,824 | 244,005 | |
3,167,921 | |||
TOTAL NONCONVERTIBLE PREFERRED STOCKS | 8,460,764 | ||
TOTAL PREFERRED STOCKS (Cost $204,311,291) | 237,751,435 | ||
Convertible Bonds - 0.2% | |||
Principal Amount (g) | Value ($) | ||
CONSUMER DISCRETIONARY - 0.2% | |||
Automobiles - 0.1% | |||
Neutron Holdings, Inc.: | |||
4% 10/27/25 (b)(c)(h) | 1,401,192 | 1,315,299 | |
4% 5/22/27 (b)(c) | 857,900 | 897,363 | |
4% 6/12/27 (b)(c) | 25,455 | 26,626 | |
2,239,288 | |||
Internet & Direct Marketing Retail - 0.1% | |||
Wayfair LLC 0.625% 10/1/25 | 19,000,000 | 14,100,361 | |
TOTAL CONSUMER DISCRETIONARY | 16,339,649 | ||
HEALTH CARE - 0.0% | |||
Health Care Equipment & Supplies - 0.0% | |||
Blink Health LLC 5% 1/15/24 (b)(c) | 3,000,000 | 3,269,100 | |
TOTAL CONVERTIBLE BONDS (Cost $20,154,429) | 19,608,749 | ||
Preferred Securities - 0.0% | |||
Principal Amount (g) | Value ($) | ||
HEALTH CARE - 0.0% | |||
Biotechnology - 0.0% | |||
Intarcia Therapeutics, Inc. 6% 7/18/23 (b)(c)(i) | 614,446 | 0 | |
Health Care Equipment & Supplies - 0.0% | |||
Kardium, Inc. 0% (b)(c)(j) | 1,612,660 | 1,570,731 | |
TOTAL HEALTH CARE | 1,570,731 | ||
INFORMATION TECHNOLOGY - 0.0% | |||
Semiconductors & Semiconductor Equipment - 0.0% | |||
GaN Systems, Inc. 0% (b)(c)(j) | 1,193,899 | 1,484,017 | |
Software - 0.0% | |||
Tenstorrent, Inc. 0% (b)(c)(j) | 1,170,000 | 1,106,820 | |
TOTAL INFORMATION TECHNOLOGY | 2,590,837 | ||
TOTAL PREFERRED SECURITIES (Cost $4,591,005) | 4,161,568 | ||
Money Market Funds - 2.3% | |||
Shares | Value ($) | ||
Fidelity Cash Central Fund 4.63% (k) | 46,673,352 | 46,682,686 | |
Fidelity Securities Lending Cash Central Fund 4.63% (k)(l) | 242,770,513 | 242,794,790 | |
TOTAL MONEY MARKET FUNDS (Cost $289,477,476) | 289,477,476 | ||
TOTAL INVESTMENT IN SECURITIES - 102.1% (Cost $7,339,489,844) | 12,850,614,042 |
NET OTHER ASSETS (LIABILITIES) - (2.1)% | (258,806,667) |
NET ASSETS - 100.0% | 12,591,807,375 |
Legend
(a) | Non-income producing |
(b) | Restricted securities (including private placements) - Investment in securities not registered under the Securities Act of 1933 (excluding 144A issues). At the end of the period, the value of restricted securities (excluding 144A issues) amounted to $442,374,586 or 3.5% of net assets. |
(c) | Level 3 security |
(d) | Security or a portion of the security is on loan at period end. |
(e) | Investment is owned by a wholly-owned subsidiary (Subsidiary) that is treated as a corporation for U.S. tax purposes. |
(f) | Security exempt from registration under Rule 144A of the Securities Act of 1933. These securities may be resold in transactions exempt from registration, normally to qualified institutional buyers. At the end of the period, the value of these securities amounted to $78,961,732 or 0.6% of net assets. |
(g) | Amount is stated in United States dollars unless otherwise noted. |
(h) | Security initially issued at one coupon which converts to a higher coupon at a specified date. The rate shown is the rate at period end. |
(i) | Non-income producing - Security is in default. |
(j) | Security is perpetual in nature with no stated maturity date. |
(k) | Affiliated fund that is generally available only to investment companies and other accounts managed by Fidelity Investments. The rate quoted is the annualized seven-day yield of the fund at period end. A complete unaudited listing of the fund's holdings as of its most recent quarter end is available upon request. In addition, each Fidelity Central Fund's financial statements are available on the SEC's website or upon request. |
(l) | Investment made with cash collateral received from securities on loan. |
Additional information on each restricted holding is as follows: | ||
Security | Acquisition Date | Acquisition Cost ($) |
Adimab LLC | 9/17/14 - 6/05/15 | 11,640,233 |
AgBiome LLC Series C | 6/29/18 | 2,144,369 |
AgBiome LLC Series D | 9/03/21 | 749,101 |
Aledade, Inc. Series B1 | 5/07/21 | 880,380 |
Aledade, Inc. Series E1 | 5/20/22 | 892,475 |
Alif Semiconductor Series C | 3/08/22 | 883,961 |
Altos Labs, Inc. Series B | 7/22/22 | 2,337,713 |
Ankyra Therapeutics Series B | 8/26/21 | 1,449,327 |
Ant International Co. Ltd. Class C | 5/16/18 | 2,351,948 |
Apogee Therapeutics Series B | 11/15/22 | 1,870,160 |
AppNexus, Inc. Series E (Escrow) | 8/01/14 | 0 |
Asimov, Inc. Series B | 10/29/21 | 1,462,779 |
Astera Labs, Inc. Series A | 5/17/22 | 874,506 |
Astera Labs, Inc. Series B | 5/17/22 | 148,902 |
Astera Labs, Inc. Series C | 8/24/21 | 1,248,909 |
Astera Labs, Inc. Series D | 5/17/22 | 2,968,386 |
Beta Technologies, Inc. Series A | 4/09/21 | 804,944 |
Beta Technologies, Inc. Series B, 6.00% | 4/04/22 | 1,769,056 |
Bird Global, Inc. | 5/11/21 | 2,283,390 |
Blink Health LLC Series A1 | 12/30/20 | 232,676 |
Blink Health LLC Series C | 11/07/19 - 7/14/21 | 7,523,268 |
Blink Health LLC 5% 1/15/24 | 7/15/22 | 3,000,000 |
Bolt Technology OU Series E | 1/03/22 | 3,525,179 |
Boundless Bio, Inc. Series B | 4/23/21 | 831,738 |
Bowery Farming, Inc. Series C1 | 5/18/21 | 1,634,925 |
Bright Peak Therapeutics AG Series B | 5/14/21 | 935,108 |
ByteDance Ltd. Series E1 | 11/18/20 | 9,288,165 |
Caris Life Sciences, Inc. | 10/06/22 | 2,217,662 |
Caris Life Sciences, Inc. Series D | 5/11/21 | 2,070,279 |
Castle Creek Biosciences, Inc. Series D1 | 4/19/22 | 959,034 |
Castle Creek Biosciences, Inc. Series D2 | 6/28/21 | 242,100 |
Castle Creek Pharmaceutical Holdings, Inc. Series A4 | 9/29/16 | 4,471,547 |
Castle Creek Pharmaceutical Holdings, Inc. Series B | 10/09/18 | 2,022,184 |
Castle Creek Pharmaceutical Holdings, Inc. Series C | 12/09/19 | 1,058,455 |
Cibus Corp. Series C | 2/16/18 - 12/02/22 | 4,144,499 |
Circle Internet Financial Ltd. Series E | 5/11/21 | 2,227,100 |
Cleerly, Inc. Series C | 7/08/22 | 3,209,483 |
Conformal Medical, Inc. Series C | 7/24/20 | 882,846 |
Cyclerion Therapeutics, Inc. | 4/02/19 | 2,229,495 |
Databricks, Inc. Series G | 2/01/21 | 3,146,861 |
Databricks, Inc. Series H | 8/31/21 | 4,148,473 |
Dataminr, Inc. Series D | 2/18/15 - 3/06/15 | 5,638,573 |
Deep Genomics, Inc. Series C | 7/21/21 | 1,878,398 |
Diamond Foundry, Inc. Series C | 3/15/21 | 8,530,704 |
Dianthus Therapeutics, Inc. Series A | 4/06/22 | 1,251,762 |
Discord, Inc. Series I | 9/15/21 | 770,874 |
DNA Script | 12/17/21 | 327,504 |
DNA Script Series B | 12/17/21 | 3,203 |
DNA Script Series C | 10/01/21 | 1,791,891 |
Dragonfly Therapeutics, Inc. | 12/19/19 | 3,336,950 |
Element Biosciences, Inc. Series B | 12/13/19 | 1,315,160 |
Element Biosciences, Inc. Series C | 6/21/21 | 2,094,954 |
ElevateBio LLC Series C | 3/09/21 | 1,394,838 |
Enevate Corp. Series E | 1/29/21 | 903,092 |
Epic Games, Inc. | 7/13/20 - 7/30/20 | 6,785,000 |
Evozyne LLC Series A | 4/09/21 | 2,278,458 |
Fanatics, Inc. Class A | 8/13/20 - 10/24/22 | 6,002,415 |
Faraday Pharmaceuticals, Inc. Series B | 12/30/19 | 288,996 |
Farmers Business Network, Inc. Series G | 9/15/21 | 2,299,217 |
Fog Pharmaceuticals, Inc. Series D | 11/17/22 | 2,664,890 |
Freenome, Inc. Series C | 8/14/20 | 1,262,201 |
Freenome, Inc. Series D | 11/22/21 | 690,407 |
Galvanize Therapeutics Series B | 3/29/22 | 1,764,020 |
GaN Systems, Inc. Series F1 | 11/30/21 | 431,946 |
GaN Systems, Inc. Series F2 | 11/30/21 | 228,087 |
GaN Systems, Inc. 0% | 11/30/21 | 1,193,899 |
Generate Biomedicines Series B | 11/02/21 | 1,865,072 |
GoBrands, Inc. Series G | 3/02/21 | 6,700,664 |
GoBrands, Inc. Series H | 7/22/21 | 8,302,821 |
Inscripta, Inc. Series D | 11/13/20 | 1,411,367 |
Inscripta, Inc. Series E | 3/30/21 | 1,963,412 |
Instacart, Inc. Series H | 11/13/20 | 834,240 |
Instacart, Inc. Series I | 2/26/21 | 792,625 |
Intarcia Therapeutics, Inc. Series EE | 9/02/16 | 6,992,640 |
Intarcia Therapeutics, Inc. 6% 7/18/23 | 2/26/19 | 614,446 |
JUUL Labs, Inc. Class A | 7/06/18 | 392,042 |
JUUL Labs, Inc. Series E | 7/06/18 | 196,006 |
Kardium, Inc. Series D6 | 12/30/20 | 1,154,861 |
Kardium, Inc. 0% | 12/30/20 | 1,612,660 |
Korro Bio, Inc. Series B1 | 12/17/21 | 630,106 |
Korro Bio, Inc. Series B2 | 12/17/21 | 630,106 |
Laronde, Inc. Series B | 8/13/21 | 1,860,096 |
LifeMine Therapeutics, Inc. Series C | 2/15/22 | 3,626,739 |
Meesho Series F | 9/21/21 | 4,789,029 |
Menlo Micro, Inc. Series C | 2/09/22 | 1,272,194 |
MOD Super Fast Pizza Holdings LLC Series 3 | 11/03/16 - 5/15/19 | 3,422,605 |
National Resilience, Inc. Series B | 12/01/20 | 3,434,780 |
National Resilience, Inc. Series C | 6/28/21 | 1,991,789 |
Neutron Holdings, Inc. | 2/04/21 | 4,384 |
Neutron Holdings, Inc. Series 1D | 1/25/19 | 1,377,091 |
Neutron Holdings, Inc. 4% 10/27/25 | 10/29/21 - 10/27/22 | 1,401,192 |
Neutron Holdings, Inc. 4% 5/22/27 | 6/04/20 | 857,900 |
Neutron Holdings, Inc. 4% 6/12/27 | 6/12/20 | 25,455 |
Nohla Therapeutics, Inc. Series B | 5/01/18 | 1,096,231 |
Oddity Tech Ltd. | 1/06/22 | 958,093 |
Odyssey Therapeutics, Inc. Series B | 9/30/22 | 2,955,958 |
Omada Health, Inc. Series E | 12/22/21 | 2,608,284 |
Paragon Biosciences Emalex Capital, Inc. Series B | 9/18/19 | 2,020,004 |
Paragon Biosciences Emalex Capital, Inc. Series C | 2/26/21 | 1,238,974 |
Paragon Biosciences Emalex Capital, Inc. Series D1 | 10/21/22 | 2,327,367 |
Paragon Biosciences Emalex Capital, Inc. Series D2 | 5/18/22 | 382,943 |
PrognomIQ, Inc. Series A5 | 8/20/20 | 50,461 |
PrognomIQ, Inc. Series B | 9/11/20 | 454,100 |
PrognomIQ, Inc. Series C | 2/16/22 | 203,508 |
Quell Therapeutics Ltd. Series B | 11/24/21 | 1,438,224 |
Rad Power Bikes, Inc. | 1/21/21 | 1,202,019 |
Rad Power Bikes, Inc. Series A | 1/21/21 | 156,712 |
Rad Power Bikes, Inc. Series C | 1/21/21 | 616,636 |
Rad Power Bikes, Inc. Series D | 9/17/21 | 2,069,142 |
Reddit, Inc. Series B | 7/26/17 | 538,544 |
Reddit, Inc. Series E | 5/18/21 | 217,765 |
Reddit, Inc. Series F | 8/11/21 | 2,498,224 |
Redwood Materials Series C | 5/28/21 | 770,449 |
SalioGen Therapeutics, Inc. Series B | 12/10/21 | 928,004 |
Saluda Medical Pty Ltd. Series D | 1/20/22 | 1,402,995 |
Saluda Medical Pty Ltd. warrants | 1/20/22 | 0 |
Scholar Rock Holding Corp. warrants 12/31/25 | 6/17/22 | 0 |
Scorpion Therapeutics, Inc. Series B | 1/08/21 | 585,688 |
SiMa.ai Series B | 5/10/21 | 1,733,641 |
SiMa.ai Series B1 | 4/25/22 | 160,595 |
Skyhawk Therapeutics, Inc. | 5/21/21 | 2,069,954 |
Skyryse, Inc. Series B | 10/21/21 | 2,891,752 |
Sonoma Biotherapeutics, Inc. Series B | 7/26/21 | 951,243 |
Sonoma Biotherapeutics, Inc. Series B1 | 7/26/21 | 760,993 |
Space Exploration Technologies Corp. Class A | 10/16/15 - 4/06/17 | 12,876,729 |
Space Exploration Technologies Corp. Series G | 1/20/15 | 4,177,960 |
SpringWorks Therapeutics, Inc. | 9/07/22 | 3,256,452 |
Stripe, Inc. Class B | 5/18/21 | 1,745,585 |
Stripe, Inc. Series H | 3/15/21 | 770,400 |
T-Knife Therapeutics, Inc. Series B | 6/30/21 | 1,150,045 |
Tenstorrent, Inc. Series C1 | 4/23/21 | 1,248,540 |
Tenstorrent, Inc. 0% | 4/23/21 | 1,170,000 |
The Beauty Health Co. | 12/08/20 | 5,538,280 |
The Oncology Institute, Inc. | 6/28/21 | 3,773,750 |
Tory Burch LLC | 5/14/15 | 17,502,223 |
Treeline Biosciences Series A | 7/30/21 - 10/27/22 | 2,267,627 |
Treeline Biosciences Series A1 | 10/27/22 | 1,236,758 |
Waymo LLC Series A2 | 5/08/20 | 921,441 |
Wugen, Inc. Series B | 7/09/21 | 750,038 |
X Holdings I, Inc. | 10/27/21 | 1,326,759 |
Xsight Labs Ltd. Series D | 2/16/21 | 1,338,418 |
Affiliated Central Funds
��
Fiscal year to date information regarding the Fund's investments in Fidelity Central Funds, including the ownership percentage, is presented below.
Affiliate | Value, beginning of period ($) | Purchases ($) | Sales Proceeds ($) | Dividend Income ($) | Realized Gain (loss) ($) | Change in Unrealized appreciation (depreciation) ($) | Value, end of period ($) | % ownership, end of period |
Fidelity Cash Central Fund 4.63% | 53,644,011 | 1,137,417,021 | 1,144,378,346 | 983,399 | - | - | 46,682,686 | 0.1% |
Fidelity Securities Lending Cash Central Fund 4.63% | 137,224,592 | 353,297,793 | 247,727,595 | 172,063 | - | - | 242,794,790 | 0.8% |
Total | 190,868,603 | 1,490,714,814 | 1,392,105,941 | 1,155,462 | - | - | 289,477,476 | |
Amounts in the dividend income column in the above table include any capital gain distributions from underlying funds.
Amount for Fidelity Securities Lending Cash Central Fund represents the income earned on investing cash collateral, less rebates paid to borrowers and any lending agent fees associated with the loan, plus any premium payments received for lending certain types of securities.
Investment Valuation
Investments are valued as of 4:00 p.m. Eastern time on the last calendar day of the period. Securities transactions are accounted for as of trade date. The Board of Trustees (the Board) has designated the Fund's investment adviser as the valuation designee responsible for the fair valuation function and performing fair value determinations as needed. The investment adviser has established a Fair Value Committee (the Committee) to carry out the day-to-day fair valuation responsibilities and has adopted policies and procedures to govern the fair valuation process and the activities of the Committee. In accordance with these fair valuation policies and procedures, which have been approved by the Board, the Fund attempts to obtain prices from one or more third party pricing services or brokers to value its investments. When current market prices, quotations or currency exchange rates are not readily available or reliable, investments will be fair valued in good faith by the Committee, in accordance with the policies and procedures. Factors used in determining fair value vary by investment type and may include market or investment specific events, transaction data, estimated cash flows, and market observations of comparable investments. The frequency that the fair valuation procedures are used cannot be predicted and they may be utilized to a significant extent. The Committee manages the Fund's fair valuation practices and maintains the fair valuation policies and procedures. The Fund's investment adviser reports to the Board information regarding the fair valuation process and related material matters.
The inputs to valuation techniques used to value investments are categorized into a disclosure hierarchy consisting of three levels as shown below:
Level 1 - Unadjusted quoted prices in active markets for identical investments
Level 2 - other significant observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds, etc.)
Level 3 - unobservable inputs (including the Fund's own assumptions based on the best information available)
Valuation techniques used to value investments by major category are as follows:
Equity securities, including restricted securities, for which market quotations are readily available, are valued at the last reported sale price or official closing price as reported by a third party pricing service on the primary market or exchange on which they are traded and are categorized as Level 1 in the hierarchy. In the event there were no sales during the day or closing prices are not available, securities are valued at the last quoted bid price or may be valued using the last available price and are generally categorized as Level 2 in the hierarchy. For any foreign equity securities, when market or security specific events arise, comparisons to the valuation of American Depositary Receipts (ADRs), futures contracts, Exchange-Traded Funds (ETFs) and certain indexes as well as quoted prices for similar securities may be used and would be categorized as Level 2 in the hierarchy. For equity securities, including restricted securities, where observable inputs are limited, assumptions about market activity and risk are used and these securities may be categorized as Level 3 in the hierarchy.
Debt securities, including restricted securities, are valued based on evaluated prices received from third party pricing services or from brokers who make markets in such securities. Convertible Bonds and Preferred Securities are valued by pricing services who utilize matrix pricing which considers yield or price of bonds of comparable quality, coupon, maturity and type or by broker-supplied prices. When independent prices are unavailable or unreliable, debt securities may be valued utilizing pricing methodologies which consider similar factors that would be used by third party pricing services. Debt securities are generally categorized as Level 2 in the hierarchy but may be Level 3 depending on the circumstances.
Investments in any open-end mutual funds are valued at their closing net asset value (NAV) each business day and are categorized as Level 1 in the hierarchy.
Changes in valuation techniques may result in transfers in or out of an assigned level within the disclosure hierarchy.
For additional information on the Fund's significant accounting policies, please refer to the Fund's most recent semiannual or annual shareholder report.
The fund's schedule of investments as of the date on the cover of this report has not been audited. This report is provided for the general information of the fund's shareholders. For more information regarding the fund and its holdings, please see the fund's most recent prospectus and annual report.
Third party trademarks and service marks are the property of their respective owners. All other trademarks and service marks are the property of FMR LLC or an affiliate.